Magnesium in PDB 5of9: Crystal Structure of Human MORC2 (Residues 1-603)
Protein crystallography data
The structure of Crystal Structure of Human MORC2 (Residues 1-603), PDB code: 5of9
was solved by
C.H.Douse,
M.Shamin,
Y.Modis,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
64.91 /
1.81
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
66.170,
127.930,
80.190,
90.00,
101.22,
90.00
|
R / Rfree (%)
|
16.1 /
18.8
|
Other elements in 5of9:
The structure of Crystal Structure of Human MORC2 (Residues 1-603) also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Crystal Structure of Human MORC2 (Residues 1-603)
(pdb code 5of9). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 2 binding sites of Magnesium where determined in the
Crystal Structure of Human MORC2 (Residues 1-603), PDB code: 5of9:
Jump to Magnesium binding site number:
1;
2;
Magnesium binding site 1 out
of 2 in 5of9
Go back to
Magnesium Binding Sites List in 5of9
Magnesium binding site 1 out
of 2 in the Crystal Structure of Human MORC2 (Residues 1-603)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Crystal Structure of Human MORC2 (Residues 1-603) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg703
b:20.8
occ:1.00
|
O2G
|
A:ANP702
|
2.0
|
19.6
|
1.0
|
O
|
A:HOH872
|
2.1
|
20.4
|
1.0
|
O1B
|
A:ANP702
|
2.1
|
22.8
|
1.0
|
OD1
|
A:ASN39
|
2.1
|
19.1
|
1.0
|
O1A
|
A:ANP702
|
2.1
|
19.7
|
1.0
|
O
|
A:HOH902
|
2.1
|
20.5
|
1.0
|
HD21
|
A:ASN39
|
3.0
|
22.8
|
1.0
|
CG
|
A:ASN39
|
3.1
|
17.7
|
1.0
|
PB
|
A:ANP702
|
3.1
|
21.6
|
1.0
|
HZ2
|
A:LYS89
|
3.2
|
24.1
|
1.0
|
PA
|
A:ANP702
|
3.3
|
21.6
|
1.0
|
PG
|
A:ANP702
|
3.3
|
20.7
|
1.0
|
ND2
|
A:ASN39
|
3.4
|
19.0
|
1.0
|
O3A
|
A:ANP702
|
3.4
|
19.5
|
1.0
|
N3B
|
A:ANP702
|
3.6
|
21.5
|
1.0
|
HA3
|
A:GLY103
|
3.7
|
26.3
|
1.0
|
O
|
A:HOH891
|
3.9
|
26.1
|
1.0
|
NZ
|
A:LYS89
|
3.9
|
20.1
|
1.0
|
HA3
|
A:GLY98
|
3.9
|
24.0
|
1.0
|
HA2
|
A:GLY98
|
3.9
|
24.0
|
1.0
|
H
|
A:GLY103
|
4.0
|
23.7
|
1.0
|
O5'
|
A:ANP702
|
4.0
|
19.9
|
1.0
|
HZ1
|
A:LYS89
|
4.0
|
24.1
|
1.0
|
HZ3
|
A:LYS89
|
4.0
|
24.1
|
1.0
|
HNB1
|
A:ANP702
|
4.1
|
25.8
|
1.0
|
H
|
A:LEU104
|
4.1
|
22.6
|
1.0
|
OE1
|
A:GLU35
|
4.1
|
24.6
|
1.0
|
O3G
|
A:ANP702
|
4.2
|
21.0
|
1.0
|
HD22
|
A:ASN39
|
4.3
|
22.8
|
1.0
|
HA
|
A:ASN39
|
4.3
|
23.3
|
1.0
|
O1G
|
A:ANP702
|
4.3
|
22.9
|
1.0
|
O
|
A:GLU35
|
4.3
|
21.9
|
1.0
|
CA
|
A:GLY98
|
4.4
|
19.9
|
1.0
|
HB2
|
A:ASP38
|
4.4
|
22.1
|
1.0
|
CB
|
A:ASN39
|
4.4
|
20.1
|
1.0
|
CA
|
A:GLY103
|
4.5
|
21.9
|
1.0
|
O2B
|
A:ANP702
|
4.5
|
20.6
|
1.0
|
N
|
A:GLY103
|
4.5
|
19.7
|
1.0
|
H3'
|
A:ANP702
|
4.5
|
25.8
|
1.0
|
O2A
|
A:ANP702
|
4.6
|
20.1
|
1.0
|
N
|
A:LEU104
|
4.6
|
18.8
|
1.0
|
HB3
|
A:GLU35
|
4.7
|
30.6
|
1.0
|
HZ2
|
A:LYS427
|
4.7
|
36.5
|
1.0
|
H
|
A:ASN39
|
4.7
|
22.4
|
1.0
|
CA
|
A:ASN39
|
4.7
|
19.4
|
1.0
|
N
|
A:ASN39
|
4.8
|
18.7
|
1.0
|
C
|
A:GLY103
|
4.9
|
19.7
|
1.0
|
HB3
|
A:ASP38
|
4.9
|
22.1
|
1.0
|
HD2
|
A:LYS89
|
4.9
|
64.8
|
1.0
|
HB3
|
A:ASN39
|
4.9
|
24.2
|
1.0
|
OD2
|
A:ASP42
|
5.0
|
28.7
|
1.0
|
HB2
|
A:ASN39
|
5.0
|
24.2
|
1.0
|
|
Magnesium binding site 2 out
of 2 in 5of9
Go back to
Magnesium Binding Sites List in 5of9
Magnesium binding site 2 out
of 2 in the Crystal Structure of Human MORC2 (Residues 1-603)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Crystal Structure of Human MORC2 (Residues 1-603) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg703
b:22.2
occ:1.00
|
O
|
B:HOH865
|
2.0
|
19.6
|
1.0
|
O1G
|
B:ANP702
|
2.0
|
23.5
|
1.0
|
OD1
|
B:ASN39
|
2.1
|
23.4
|
1.0
|
O
|
B:HOH907
|
2.1
|
23.2
|
1.0
|
O1A
|
B:ANP702
|
2.1
|
20.4
|
1.0
|
O1B
|
B:ANP702
|
2.1
|
21.0
|
1.0
|
HD21
|
B:ASN39
|
3.0
|
29.0
|
1.0
|
CG
|
B:ASN39
|
3.0
|
23.1
|
1.0
|
PB
|
B:ANP702
|
3.2
|
20.9
|
1.0
|
HZ2
|
B:LYS89
|
3.3
|
27.2
|
1.0
|
PA
|
B:ANP702
|
3.3
|
23.8
|
1.0
|
PG
|
B:ANP702
|
3.3
|
25.6
|
1.0
|
ND2
|
B:ASN39
|
3.4
|
24.1
|
1.0
|
O3A
|
B:ANP702
|
3.4
|
22.0
|
1.0
|
N3B
|
B:ANP702
|
3.6
|
19.9
|
1.0
|
HA3
|
B:GLY103
|
3.7
|
25.9
|
1.0
|
H
|
B:GLY103
|
3.9
|
25.2
|
1.0
|
HA3
|
B:GLY98
|
3.9
|
34.0
|
1.0
|
O
|
B:HOH910
|
3.9
|
23.7
|
1.0
|
NZ
|
B:LYS89
|
4.0
|
22.6
|
1.0
|
O5'
|
B:ANP702
|
4.0
|
23.8
|
1.0
|
HA2
|
B:GLY98
|
4.0
|
34.0
|
1.0
|
H
|
B:LEU104
|
4.0
|
25.3
|
1.0
|
HZ1
|
B:LYS89
|
4.0
|
27.2
|
1.0
|
HZ3
|
B:LYS89
|
4.1
|
27.2
|
1.0
|
OE2
|
B:GLU35
|
4.1
|
27.5
|
1.0
|
HD22
|
B:ASN39
|
4.2
|
29.0
|
1.0
|
HA
|
B:ASN39
|
4.3
|
29.8
|
1.0
|
O3G
|
B:ANP702
|
4.3
|
21.9
|
1.0
|
O
|
B:GLU35
|
4.3
|
21.3
|
1.0
|
O2G
|
B:ANP702
|
4.4
|
23.4
|
1.0
|
CB
|
B:ASN39
|
4.4
|
20.8
|
1.0
|
CA
|
B:GLY98
|
4.4
|
28.3
|
1.0
|
CA
|
B:GLY103
|
4.4
|
21.6
|
1.0
|
N
|
B:GLY103
|
4.4
|
21.0
|
1.0
|
HNB1
|
B:ANP702
|
4.5
|
24.0
|
1.0
|
HB2
|
B:ASP38
|
4.5
|
26.3
|
1.0
|
N
|
B:LEU104
|
4.5
|
21.1
|
1.0
|
O2B
|
B:ANP702
|
4.5
|
24.4
|
1.0
|
H3'
|
B:ANP702
|
4.6
|
30.0
|
1.0
|
O2A
|
B:ANP702
|
4.6
|
21.4
|
1.0
|
H
|
B:ASN39
|
4.7
|
29.3
|
1.0
|
HB3
|
B:GLU35
|
4.7
|
25.2
|
1.0
|
CA
|
B:ASN39
|
4.7
|
24.8
|
1.0
|
N
|
B:ASN39
|
4.8
|
24.4
|
1.0
|
HZ2
|
B:LYS427
|
4.8
|
48.5
|
1.0
|
C
|
B:GLY103
|
4.9
|
19.5
|
1.0
|
HB3
|
B:ASP38
|
4.9
|
26.3
|
1.0
|
HB3
|
B:ASN39
|
4.9
|
25.0
|
1.0
|
HB2
|
B:ASN39
|
4.9
|
25.0
|
1.0
|
OD2
|
B:ASP42
|
4.9
|
29.8
|
1.0
|
HB2
|
B:LEU104
|
5.0
|
24.2
|
1.0
|
|
Reference:
C.H.Douse,
S.Bloor,
Y.Liu,
M.Shamin,
I.A.Tchasovnikarova,
R.T.Timms,
P.J.Lehner,
Y.Modis.
Neuropathic MORC2 Mutations Perturb Ghkl Atpase Dimerization Dynamics and Epigenetic Silencing By Multiple Structural Mechanisms. Nat Commun V. 9 651 2018.
ISSN: ESSN 2041-1723
PubMed: 29440755
DOI: 10.1038/S41467-018-03045-X
Page generated: Mon Sep 30 00:57:35 2024
|